155 related articles for article (PubMed ID: 32359095)
1. In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management.
Okur NÜ; Yozgatli V; Okur ME
Drug Dev Res; 2020 Sep; 81(6):716-727. PubMed ID: 32359095
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis.
Shen T; Yang Z
Drug Des Devel Ther; 2021; 15():2099-2107. PubMed ID: 34040348
[TBL] [Abstract][Full Text] [Related]
3. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
5. Preparation of levofloxacin loaded
Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z
Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154
[TBL] [Abstract][Full Text] [Related]
6. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
8. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
[TBL] [Abstract][Full Text] [Related]
9. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
[TBL] [Abstract][Full Text] [Related]
10. Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro.
Perminaite K; Marksa M; Stančiauskaitė M; Juknius T; Grigonis A; Ramanauskiene K
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200887
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-based thermosensitive hydrogel as a promising ocular drug delivery system: preparation, characterization, and in vivo evaluation.
Chen X; Li X; Zhou Y; Wang X; Zhang Y; Fan Y; Huang Y; Liu Y
J Biomater Appl; 2012 Nov; 27(4):391-402. PubMed ID: 21750179
[TBL] [Abstract][Full Text] [Related]
12. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.
Abdelbary GA; Amin MM; Zakaria MY
Drug Deliv; 2017 Nov; 24(1):309-319. PubMed ID: 28165809
[TBL] [Abstract][Full Text] [Related]
13. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
14. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
15. A Novel Phytantriol-Based Lyotropic Liquid Crystalline Gel for Efficient Ophthalmic Delivery of Pilocarpine Nitrate.
Wang X; Zhang Y; Huang J; Tian C; Xia M; Liu L; Li Z; Cao J; Gui S; Chu X
AAPS PharmSciTech; 2019 Jan; 20(1):32. PubMed ID: 30603986
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.
Saher O; Ghorab DM; Mursi NM
Pharm Dev Technol; 2016 Aug; 21(5):600-10. PubMed ID: 25886078
[TBL] [Abstract][Full Text] [Related]
17. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
Senjoti FG; Timmins P; Conway BR; Smith AM
Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
[TBL] [Abstract][Full Text] [Related]
18. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
Khan S; Warade S; Singhavi DJ
J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
[TBL] [Abstract][Full Text] [Related]
20. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery.
Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S
Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
